Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Muheez A. Durosinmi · Sankore

Osun State University

Muheez A. Durosinmi

ORCID, self-asserted

ORCID 0000-0003-1984-5962

This profile carries an ORCID the researcher published on their own record — the strongest evidence available short of a human confirming it. 1 other profile was folded into this one.

Publications

8

Citations

2

h-index

1

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

0

Works published 2022 onward have been swept for this country. Figures are complete within that window, to the extent the open indexes are.

Affiliations

Every institution this scholar has appeared with on a work, by how many.

Obafemi Awolowo University6 works
Osun State University5 works
Obafemi Awolowo University Teaching Hospitals Complex4 works
Adekunle Ajasin University1 works
Ekiti State University1 works

Publications

8 works in the graph, newest first.

Long-term survival and successful pregnancy in a Nigerian woman with concurrent diagnosis of non-Hodgkin lymphoma and chronic myeloid leukemia: a case report
2026Journal of Medical Case ReportsJournalOpen accessSenior author0 citations10.1186/s13256-025-05773-3
Chronic Myelogenous Leukaemia in the Era of Molecular Therapy
2026IntechOpen eBooksBook ChapterOpen accessSenior authorCorresponding0 citations10.5772/intechopen.1014112
POSTER: CML-029: Reduction in Thyroid Volume in Patients With Chronic Myeloid Leukemia After Imatinib Treatment: A Prospective Cohort Study
2026Clinical Lymphoma Myeloma & LeukemiaJournalSenior author0 citations10.1016/s2152-2650(26)00779-2
Imatinib Induced Thyroid Dysfunction in BCR::ABL1 Positive Chronic Myeloid Leukaemia Patients: Sokal Score as a Predictor
2025Indian Journal of Hematology and Blood TransfusionJournalSenior author0 citations10.1007/s12288-024-01940-6

Reduction in thyroid volume in chronic myeloid leukemia patients after imatinib treatment: a longitudinal study

2025Hematology in Clinical PracticeJournalOpen accessSenior author0 citations10.5603/hicp.99834

Late presentation of chronic myeloid leukaemia patients in a low-income country: the prognostic implications and impact on treatment outcome.

2024PubMedJournalOpen accessSenior author0 citations10.1186/s13104-024-06910-9

Subclinical Hypothyroidism Following Imatinib Use in Nigerian BCR::ABL1-positive Chronic Myeloid Leukemia Patients: A Prospective Cohort Study

2024Journal of Applied HematologyJournalOpen accessSenior author2 citations10.4103/joah.joah_121_23

Comparative Assessment of Echocardiographic Patterns Among Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor and Healthy Controls

2022Dove Medical Press (Taylor and Francis Group)JournalOpen access0 citations10.2147/vhrm.s348744